Your browser doesn't support javascript.
loading
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Sakashita, Takuya; Yanagitani, Noriko; Koike, Sumie; Low, Siew-Kee; Takagi, Satoshi; Baba, Satoko; Takeuchi, Kengo; Nishio, Makoto; Fujita, Naoya; Katayama, Ryohei.
Affiliation
  • Sakashita T; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yanagitani N; Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Koike S; Science Enablement Department, Science & Data Analytics Division, Research & Development, AstraZeneca K.K, Osaka, Japan.
  • Low SK; Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takagi S; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Baba S; Cancer Precision Medicine Center, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takeuchi K; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nishio M; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Fujita N; Pathology Project for Molecular Targets, the Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Katayama R; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Cancer Sci ; 113(11): 3888-3900, 2022 Nov.
Article in En | MEDLINE | ID: mdl-35950895
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Receptor, Fibroblast Growth Factor, Type 3 / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Sci Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Receptor, Fibroblast Growth Factor, Type 3 / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Sci Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Reino Unido